总时间（秒）：35.38
问答时间（秒）：33.20

<think>
Okay, let's tackle this query step by step. The user wants information extracted from the given scientific literature about genetic variants, the disease they're associated with, and the experimental methods used. The output needs to be in a specific JSON format with standardized HGVS nomenclature and MONDO terms. 

First, I need to identify the gene and variants mentioned. The article talks about parkin, specifically the ubiquitin-like domain (Uld) with mutants K27N, R33Q, R42P, K48A, and V56E. These are the variants. The gene is PARK2, as parkin is the protein product of the PARK2 gene. Next, the disease associated here is autosomal recessive juvenile Parkinsonism (AR-JP). I need to find the MONDO term for AR-JP. I'll check MONDO and find that the term is MONDO:0013193.

Now, the variants. The paper lists five mutants: K27N, R33Q, R42P, K48A, and V56E. However, the user's example uses HGVS nomenclature with transcript numbers. The problem is that the original text doesn't provide transcript IDs or specific nucleotide changes. The variants are described as amino acid substitutions, but without the exact cDNA changes, I can't generate the full HGVS notation. Since the user requires standardization via API, but the input doesn't have the necessary details, I have to note that as N.D. for the cDNA change. But wait, the user's example shows that even if the cDNA is not provided, they can use the protein change. However, the HGVS standard requires the transcript ID. Since the paper doesn't mention it, I'll have to use N.D. for the transcript and cDNA positions, but the protein change can be specified.

Next, the experimental methods. The study uses X-ray crystallography and molecular dynamics simulations. The material used is the parkin Uld domain. The readout types would be structural and functional. The results describe the effects of each mutation on the protein structure and dynamics. However, the literature doesn't mention biological or technical replicates, controls, or statistical methods. So those fields will be N.D. unless I can infer from the context. The approved assay might be N.D. since the methods are structural and not standard clinical assays.

Putting it all together, the JSON structure will have the variants with N.D. for some fields, the disease with the MONDO term, and the experimental methods with details as per the paper. I need to ensure that all required fields are present even if their values are N.D. or not applicable.
</think>

{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "K",
            "alt": "N",
            "position": "27"
          },
          "Description in input context": "K27N mutation in parkin's ubiquitin-like domain (Uld)"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "R",
            "alt": "Q",
            "position": "33"
          },
          "Description in input context": "R33Q mutation in parkin's Uld"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "42"
          },
          "Description in input context": "R42P mutation in parkin's Uld"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "K",
            "alt": "A",
            "position": "48"
          },
          "Description in input context": "K48A mutation in parkin's Uld"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "V",
            "alt": "E",
            "position": "56"
          },
          "Description in input context": "V56E mutation in parkin's Uld"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal recessive juvenile Parkinsonism (AR-JP)",
    "MONDO": "MONDO:0013193"
  },
  "Experiment Method": [
    {
      "Assay Method": "X-ray crystallography and molecular dynamics simulations",
      "Material used": {
        "Material Source": "Protein structure",
        "Material Name": "Parkin ubiquitin-like domain (Uld)",
        "Description": "Structural analysis of wild-type and mutant parkin Uld using crystallography and molecular dynamics."
      },
      "Readout type": "Structural and functional analysis",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Structural analysis revealed altered conformational dynamics and interactions in mutants K27N, R33Q, R42P, K48A, and V56E. K27N showed reduced stability; R33Q disrupted intermolecular contacts; R42P altered binding orientation; K48A impaired domain flexibility; V56E affected hydrogen bonding."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}